two
receptor
bind
variant
influenza
viru
hlnll
separ
differ
plaqu
format
mdck
cell
hemagglutin
variant
restrict
red
blood
cell
guinea
pig
wherea
variant
ii
also
hemagglutin
chicken
cell
variant
differ
also
abil
bind
sialic
acid
evid
present
differ
determin
complex
carbohydr
side
chain
asparagin
near
receptor
bind
site
absent
variant
ii
variant
arginin
found
cleavag
site
human
isol
analyz
far
replac
lysin
viru
trigger
penetr
nucleocapsid
cell
klenk
rott
therefor
host
chang
often
accompani
chang
receptor
specif
caus
alter
receptor
bind
site
rb
adapt
origin
viru
isol
phase
new
host
select
spontan
viru
variant
phase
differ
receptor
bind
characterist
report
first
burnet
bull
sinc
time
larg
number
influenza
viru
variant
differ
receptor
bind
capac
isol
passag
differ
host
cell
presenc
rb
specif
antibodi
cohen
biddl
creceliu
et
al
daniel
et
al
gitelman
et
al
katz
webster
katz
et
al
oxford
et
al
oxford
et
al
robertson
et
al
robertson
et
al
robertson
et
al
schild
et
al
use
variou
serum
hemagglutin
inhibitor
roger
et
al
bind
artifici
receptor
roger
et
al
chang
due
ha
mutat
influenza
burnet
bull
present
studi
show
mutat
respons
chang
receptor
bind
specif
consist
loss
carbohydr
side
chain
locat
close
proxim
receptor
bind
site
scholtissek
et
al
plaqu
hemagglutin
hemagglutin
inhibit
test
carri
standard
procedur
plaqu
assay
perform
mdck
cell
cultur
presenc
pg
trypsin
per
ml
overlay
medium
hemagglutin
done
microtit
plate
use
guinea
pig
chick
erythrocyt
concentr
phosphatebuff
salin
pb
method
enzymat
modif
chicken
erythrocyt
oligosaccharid
includ
deand
resialyl
accord
instruct
schultz
cowork
briefli
sialic
acid
remov
glycoconjug
treatment
erythrocyt
mm
nacl
mm
cacl
mm
me
ph
neuraminidas
tibrio
choleru
endoglycosidas
f
endo
f
ec
use
remov
nlink
carbohydr
side
chain
viral
glycoprotein
radioact
label
viru
hau
incub
mm
phosphat
buffer
ph
contain
sd
presenc
mercaptoethanol
unit
endo
f
h
total
volum
proteolyt
cleavag
radioact
label
viru
hau
incub
min
unit
trypsin
ec
pb
unit
endoproteinas
argc
ec
potassium
phosphat
buffer
ph
unit
endoproteinas
lysc
mm
mm
edta
buffer
ph
enzym
boehring
mannheim
germani
enzym
reaction
stop
addit
sampl
buffer
gel
electrophoresi
without
mercaptoethanol
ha
electrophoret
separ
polyacrylamid
gel
reduc
condit
visual
fluorographi
antibodi
rais
purifi
influenza
viru
glycoprotein
solubil
noctylglucosid
separ
ultracentrifug
nucleocapsid
kohama
et
al
use
repeat
subcutan
inject
rabbit
western
blot
done
describ
kuroda
et
al
vrna
mrna
isol
use
standard
procedur
sequenc
primer
extens
method
describ
done
evan
sutherland
comput
use
coordin
deposit
brookhaven
protein
data
bank
softwar
program
version
kindli
provid
gerrit
vriend
embl
heidelberg
germani
mix
viru
popul
clinic
sampl
receptor
bind
variant
isol
differenti
plaqu
format
mdck
cell
presenc
trypsin
plaqu
passag
plaqu
variant
obtain
variant
form
fuzzi
plaqu
size
k
mm
diamet
h
pi
agglutin
erythrocyt
guinea
pig
chicken
variant
ii
differ
receptor
specif
shown
tabl
red
blood
cell
guinea
pig
bound
virus
analyz
wherea
untreat
chicken
cell
agglutin
hl
virus
except
variant
elucid
receptor
specif
desialyl
chicken
cell
reconstitut
sialic
acid
sa
either
linkag
use
viru
agglutin
contrast
variant
variant
ii
recogn
sialic
acid
linkag
strain
wsn
abil
variant
ii
util
sequenc
agre
previou
find
hl
isol
sinc
receptor
specif
roger
dsouza
hand
sinc
variant
bind
either
resialyl
erythrocyt
use
exact
receptor
specif
still
unknown
differ
receptor
specif
variant
expect
structur
distinguish
therefor
variant
first
analyz
electrophoresi
polyacrylamid
gel
subunit
ha
variant
migrat
slowli
variant
ii
fig
shift
molecular
weight
dalton
might
caus
one
carbohydr
side
chain
complet
remov
carbohydr
treatment
endoglycosidas
f
result
ha
subunit
design
ha
ident
size
indic
carbohydr
respons
molecular
weight
shift
fig
local
attach
site
addit
carbohydr
ha
variant
variant
compar
rna
sequenc
primari
structur
could
character
primer
extens
sequenc
method
residu
sequenc
determin
clone
cytidin
variant
replac
uridin
exchang
lead
isoleucin
amino
acid
posit
amino
acid
sequenc
variant
ha
fig
ha
variant
possess
threonin
residu
posit
provid
nglycosyl
signal
combin
asparagin
posit
thu
ha
variant
ii
lost
nglycosyl
site
variant
contain
glycosyl
site
amino
acid
posit
ha
ha
affect
chang
receptor
specif
fig
asparagin
posit
glycosyl
waterfield
et
al
steric
hindranc
carbohydr
asparagin
use
primer
extens
method
sequenc
clone
gene
fragment
variant
lysin
surprisingli
found
singl
amino
acid
connect
ha
ha
fig
interest
see
whether
hl
virus
isol
time
also
contain
lysin
ha
cleavag
site
therefor
addit
viru
isol
obtain
tiibingen
hannov
time
cours
analyz
critic
site
ha
level
vrna
cdna
howev
isol
contain
lysin
ha
cleavag
site
human
influenza
viru
isol
analyz
far
singl
arginin
posit
consequ
unusu
ha
cleavag
site
tiibingen
isol
endoproteinas
specif
lysin
activ
influenza
viru
vitro
notan
enzym
specif
arginin
therefor
variant
ii
control
two
influenza
virus
correspond
arginin
residu
site
treat
either
trypsin
endoproteinas
argc
mous
submaxillari
gland
endoproteinas
lysc
lysobact
enzymogen
respect
thereaft
analyz
sdspage
reduc
condit
fig
expect
virus
activ
trypsin
klenk
et
al
howev
endoproteinas
argc
cleav
ha
tiibingen
isol
wherea
influenza
viru
strain
wsn
viru
n
singl
arginin
posit
cleav
endoproteinas
lysc
degrad
total
therefor
unsuit
proteolyt
activ
present
studi
character
variant
human
influenza
hlnl
isol
obtain
serial
passag
mdck
cell
variant
distinguish
receptor
bind
specif
differ
determin
oligosaccharid
asn
due
mutat
amino
acid
posit
present
variant
absent
variant
ii
amino
acid
posit
part
rb
nobusawa
et
al
chang
amino
acid
alon
may
modifi
receptor
specif
like
main
structur
alter
presenc
absenc
carbohydr
side
chain
posit
critic
shift
receptor
specif
carbohydr
may
either
indirect
effect
fold
ha
polypeptid
rb
like
may
directli
prevent
access
wei
et
al
nobusawa
et
al
pc
asparaginet
variant
indic
uenza
iomer
acid
lsition
use
experi
thu
receptor
could
determin
resialyl
experi
altern
low
bind
affin
linkag
type
analyz
also
explain
receptor
specif
detect
third
possibl
variant
viru
bind
neither
sialic
acid
rule
either
sever
group
demonstr
similar
chang
receptor
specif
base
singl
amino
acid
chang
rb
also
alter
carbohydr
equip
thu
variant
influenza
hlnl
viru
describ
differ
origin
viru
receptor
bind
capac
blood
cell
guinea
pig
gitelman
et
al
differ
caus
carbohydr
side
chain
respons
receptor
bind
variat
analyz
present
studi
carbohydr
posit
also
lost
eggadapt
hlnl
viru
robertson
et
al
furthermor
host
cell
mutant
influenza
viru
awsn
hlnl
acquir
carbohydr
asparagin
eom
et
al
two
amino
acid
away
carbohydr
attach
site
tiibingen
variant
show
reduc
bind
receptor
aytay
schulz
chang
carbohydr
follow
egg
adapt
detect
hl
isol
also
isol
katz
webster
wang
et
al
katz
et
al
influenza
b
variant
robertson
et
al
oxford
et
al
take
data
togeth
find
give
strong
evid
carbohydr
around
rb
play
import
role
receptor
specif
determin
host
tropism
case
nevertheless
amino
acid
substitut
without
alter
carbohydr
exist
around
receptor
bind
domain
mani
influenza
b
virus
affect
bind
activ
specif
et
al
roger
et
al
b
naev
et
al
nobusawa
nakajima
katz
webster
suzuki
et
al
katz
et
al
nobusawa
et
al
hand
chang
carbohydr
appear
around
rb
without
obviou
chang
receptor
specif
may
import
antigen
drift
skehel
et
al
seidel
et
al
antigen
modul
carbohydr
shift
posit
antigen
epitop
sb
hl
variant
select
presenc
monoclon
antibodi
yate
et
al
whether
antigen
alter
occur
tiibingen
variant
show
amino
acid
exchang
epitop
investig
may
relev
epidemiolog
aspect
consid
vaccin
product
tiibingen
isol
contain
either
priori
subpopul
least
two
variant
distinguish
receptor
specif
carbohydr
content
less
like
variant
primarili
present
rapidli
convert
variant
ii
propag
perform
mdck
cell
find
indic
mdck
cellderiv
virus
inevit
repres
situat
influenzainfect
individu
contrast
result
robertson
cowork
show
ident
directli
analyz
ha
code
region
clinic
materi
viru
propag
mdck
cell
moreov
identif
rbss
virus
clinic
specimen
embryon
hen
egg
shown
rajakumar
et
al
variant
strain
unusu
proteolyt
activ
site
hemagglutinin
consist
singl
lysin
cleavag
site
observ
serotyp
present
avian
isol
kawaoka
et
al
mammalian
apathogen
avian
influenza
virus
singl
arginin
posit
arginin
also
found
analyz
cleavag
site
human
hl
isol
obtain
subsequ
year
variou
place
germani
data
shown
sinc
trypsin
use
isol
procedur
variant
discrimin
lysin
arginin
cleavag
site
like
select
pressur
favour
mutat
arginin
lysin
isol
thu
reason
assum
lysin
cleavag
site
exist
alreadi
origin
clinic
specimen
human
alveolar
system
therefor
contain
appropri
proteas
activ
lysin
enzym
must
also
present
chick
embryo
allow
viru
replic
without
substitut
exogen
proteas
whether
chick
embryo
enzym
ident
factor
xlike
activ
arginin
site
describ
gotoh
cowork
remain
seen
ogasawara
et
al
howev
data
present
show
clearli
depend
presenc
arginin
lysin
cleavag
site
hl
hemagglutinin
discrimin
activ
proteas
interest
see
whether
differ
effect
pathogen
biolog
properti
viru
